Pharmacological management of binge eating disorder
1(Corresponding author) Supervising Clinical Pharmacist, Behavioral Health Pharmacy Services Riverside University Health System Medical Center, Riverside, California, andrew.williams@ruhealth.org.
Abstract:
Treatment guidelines for binge eating disorder (BED) lack substantial recommendations for specific pharmacological management beyond lisdexamfetamine. This may lead clinicians to question what other options are available for managing BED. The following clinical scenarios will review existing data examining the use of several pharmacological agents for BED, including stimulants, glucagon-like peptide-1 agonists, naltrexone, antidepressants, and antiseizure medications.
Related Concept Videos
Binge Eating Disorders
Bulimia Nervosa
Regulation of Food Intake
Antidepressant Drugs: MAOIs and Other Agents
Mania and Antimanic Drugs: Overview
Management of Insomnia


